Tatjana Crnogorac-Jurcevic
Overview
Explore the profile of Tatjana Crnogorac-Jurcevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
2023
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tajbakhsh J, Debernardi S, Blyuss O, Bai J, Weng R, Lo S, et al.
J Mol Diagn
. 2024 Nov;
27(1):54-61.
PMID: 39521243
A noninvasive test for earlier detection of pancreatic cancer in individuals at higher risk is currently unavailable. We devised PancSure, a laboratory-developed test based on the protein biomarkers lymphatic vessel...
2.
Ali N, Debernardi S, Kurotova E, Tajbakhsh J, Gupta N, Pandol S, et al.
Front Oncol
. 2024 Sep;
14:1450326.
PMID: 39309742
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death worldwide. Up to now, no specific screening or diagnostic tests are available for early PDAC detection. As...
3.
Schilling K, Chen H, Glabonjat R, Debernardi S, Blyuss O, Navas-Acien A, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1332895.
PMID: 38694937
Background: More than 700 million people worldwide suffer from diseases of the pancreas, such as diabetes, pancreatitis and pancreatic cancer. Often dysregulation of potassium (K) channels, co-transporters and pumps can...
4.
Debernardi S, Liszka L, Ntala C, Steiger K, Esposito I, Carlotti E, et al.
Mol Oncol
. 2023 Dec;
18(3):677-690.
PMID: 38145461
The median age of patients with pancreatic ductal adenocarcinoma (PDAC) at diagnosis is 71 years; however, around 10% present with early-onset pancreatic cancer (EOPC), i.e., before age 50. The molecular...
5.
Mikolaskova I, Crnogorac-Jurcevic T, Smolkova B, Hunakova L
Biology (Basel)
. 2023 Feb;
12(2).
PMID: 36829437
The correlation between pancreatic ductal adenocarcinoma (PDAC) and diabetes-related mechanisms support the hypothesis that early therapeutic strategies targeting diabetes can contribute to PDAC risk reduction and treatment improvement. A systematic...
6.
Saman H, Raza A, Patil K, Uddin S, Crnogorac-Jurcevic T
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497263
Worldwide, lung cancer (LC) is the most common cause of cancer death, and any delay in the detection of new and relapsed disease serves as a major factor for a...
7.
Pan S, Lai L, Simeone D, Dawson D, Yan Y, Crnogorac-Jurcevic T, et al.
Pancreas
. 2022 Nov;
51(7):790-799.
PMID: 36395405
Objectives: Extracellular vesicles (EVs) are lipid bound vesicles secreted by cells into the extracellular environment. Studies have implicated EVs in cell proliferation, epithelial-mesenchymal transition, metastasis, angiogenesis, and mediating the interaction...
8.
Debernardi S, Blyuss O, Rycyk D, Srivastava K, Jeon C, Cai H, et al.
Int J Cancer
. 2022 Sep;
152(4):769-780.
PMID: 36093581
The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly attributed to late diagnosis. We assessed the predictive performance of our previously reported urine biomarker panel for earlier detection of...
9.
Jach D, Cheng Y, Prica F, Dumartin L, Crnogorac-Jurcevic T
Am J Cancer Res
. 2021 Dec;
11(11):5249-5262.
PMID: 34873459
Anterior gradient 2, AGR2, is a small, 20 kDa protein that plays a vital role in oxidative protein folding in the endoplasmic reticulum. AGR2 is involved in several signal transduction...
10.
Kumar S, Jach D, Macfarlane W, Crnogorac-Jurcevic T
Pancreas
. 2021 Oct;
50(7):982-989.
PMID: 34629448
Objectives: To facilitate exploring a link between pancreatic ductal adenocarcinoma (PDAC) and diabetes mellitus, we constructed a novel 3-dimensional (3D) in vitro coculturing system for studying interactions between PDAC and...